Related Experiment Video
Updated: Jul 18, 2026

05:30
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
Published on: October 31, 2025
Emerging dermatologic issues in the oncology patient
Steven R Mays1, Philip R Cohen
1Department of Dermatology, MD Anderson Cancer Center, Houston, TX 77030, USA. stevenmays@earthlink.net
Seminars in Cutaneous Medicine and Surgery
|December 19, 2006
Summary
Cancer patients experience unique skin conditions, including invasive mold infections and chemotherapy-induced eruptions. Leukemia and lymphoma patients face increased risks of fungal infections and skin cancers like squamous cell carcinoma.
Area of Science:
- Dermatology
- Oncology
- Infectious Diseases
Background:
- Cancer patients, particularly those with leukemia/lymphoma, exhibit distinct skin disease patterns compared to other immunosuppressed individuals.
- Invasive mold infections, especially Aspergillus, are a leading cause of mortality in leukemia/lymphoma patients.
- Certain chemotherapy agents and specific hematologic malignancies are associated with unique dermatologic toxicities.
Purpose of the Study:
- To review the spectrum of cutaneous manifestations in oncology patients.
- To highlight invasive mold infections in leukemia/lymphoma patients.
- To discuss chemotherapy-induced pustular eruptions and increased skin cancer risk in specific patient groups.
Main Methods:
- Literature review focusing on cutaneous manifestations in oncology patients.
- Analysis of data concerning invasive mold infections in leukemia/lymphoma populations.
- Examination of chemotherapy-related dermatologic side effects and skin cancer incidence.
Main Results:
- Aspergillus mold infections are the primary infectious cause of death in leukemia/lymphoma patients.
- A new class of chemotherapy for solid tumors can cause pustular eruptions.
- Chronic lymphocytic leukemia and non-Hodgkin's lymphoma patients have a higher incidence of cutaneous squamous cell and basal cell carcinomas, often with a more aggressive course.
Conclusions:
- Skin manifestations in cancer patients are diverse and require specific recognition.
- Invasive fungal infections and iatrogenic skin conditions pose significant risks in immunosuppressed cancer patients.
- Increased surveillance for skin cancers is warranted in certain leukemia and lymphoma populations due to higher frequency and aggressive behavior.
Related Concept Videos
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Changes in Skin Color: Clinical Perspectives
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.